Method for reducing side effects from administration of phosphodiesterase-4 inhibitors Grant US-12042487-B2 United States of America 23 Jul 2024
Roflumilast formulations with an improved pharmacokinetic profile Grant US-12016848-B2 United States of America 25 Jun 2024
Roflumilast formulations with an improved pharmacokinetic profile Grant US-12011437-B1 United States of America 18 Jun 2024
Topical roflumilast formulation having improved delivery and plasma half-life Grant US-12005052-B2 United States of America 11 Jun 2024